Top Biotechnology & Medical Research stocks in North America
Researchers and developers of biotechnology based drugs and therapies as well as medical devices and procedures that are at an early (non-commercial) stage.
Name | Market Cap | Price to Earnings TTM | Dividend Yield % TTM |
---|---|---|---|
FDMT4D Molecular Therapeutics | $744.53m | n/a | n/a |
NUVBNuvation Bio | $741.51m | n/a | n/a |
SAGESage Therapeutics | $739.64m | n/a | n/a |
RAPPRapport Therapeutics | $735.92m | n/a | n/a |
SVRASavara | $734.97m | n/a | n/a |
CRGXCARGO Therapeutics | $725.76m | n/a | n/a |
LXRXLexicon Pharmaceuticals | $719.27m | n/a | n/a |
WVEWave Life Sciences | $715.25m | n/a | n/a |
STOKStoke Therapeutics | $707.79m | n/a | n/a |
ERASErasca | $702.05m | n/a | n/a |
ZYMEZymeworks | $697.07m | n/a | n/a |
ABUSArbutus Biopharma | $696.37m | n/a | n/a |
SRRKScholar Rock Holding | $694.66m | n/a | n/a |
ORICORIC Pharmaceuticals | $689.06m | n/a | n/a |
SSIISS Innovations International | $682.96m | n/a | n/a |
REPLReplimune | $663.46m | n/a | n/a |
MLYSMineralys Therapeutics | $655.36m | n/a | n/a |
URGNUrogen Pharma | $650.07m | n/a | n/a |
ALMSAlumis | $648.06m | n/a | n/a |
SLRNAcelyrin | $644.67m | n/a | n/a |